-+ 0.00%
-+ 0.00%
-+ 0.00%

Mira Pharmaceuticals Launches Phase 1 Trial of Oral Ketamir-2 for Chemotherapy-Induced Neuropathic Pain

Reuters·10/23/2025 20:02:35

Please log in to view news